Denosumab and Osteoporosis. In the following table are summary statistics from Exercise 16.61 on body-mass indexes (BMI)

of the women in five denosumab treatment groups. Use a family confidence level of 0.90. Here qα = 3.50.

Treatment nj x¯j sj Placebo 46 25.9 4.3 14 mg 54 25.8 5.3 60 mg 47 27.5 5.8 100 mg 42 26.0 4.6 210 mg 47 25.9 4.3